Clinical Trial Update: A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial in relapsing-remitting multiple sclerosis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: TERMINATED | Results posted: 2020-02-10